Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Aytu Biopharma (AYTU) Receivables - Other (2021)

Historic Receivables - Other for Aytu Biopharma (AYTU) over the last 2 years, with Q3 2021 value amounting to $9000.0.

Aytu Biopharma's Receivables - Other changed N/A to $9000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $9000.0, marking a year-over-year change of. This contributed to the annual value of $21000.0 for FY2021, which is N/A changed from last year.
As of Q3 2021, Aytu Biopharma's Receivables - Other stood at $9000.0.
Aytu Biopharma's Receivables - Other's 5-year high stood at $42000.0 during Q1 2021, with a 5-year trough of $9000.0 in Q3 2021.